Director, Toronto Scleroderma Program
University of Toronto
Dr. Johnson is a Consultant Rheumatologist in the Division of Rheumatology at the University Health Network and Mount Sinai Hospitals, Department of Medicine and Institute of Health Policy, Management and Evaluation at the University of Toronto. She is Director of the Toronto Scleroderma Program. She is Co-Chair of the American College of Rheumatology (ACR) Classification and Response Criteria subcommittee. In addition, Dr. Johnson was a methodologic lead on the steering committee for the development of the 2013 ACR – European League Against Rheumatism Classification Criteria for Systemic Sclerosis. She is currently the ACR lead for the development of classification criteria for systemic lupus erythematosus and Co-Chair for the development of systemic sclerosis subset criteria.